Drugs / BC8-SA
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00988715 | Apr 2010 → Jan 2015 | acute myeloid leukemia, adult acute lymphoblastic leukemia, chronic myelomonocytic leukemia, myelodysplastic syndrome with excess blasts +2 | Fred Hutchinson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BC8-SA | “BC8-SA (BC8 antibody-streptavidin conjugate)” NCT00988715 ↗ |
| Known as | BC8 antibody-streptavidin conjugate | “BC8-SA (BC8 antibody-streptavidin conjugate)” NCT00988715 ↗ |
| Route | Intravenous | “test dose of BC8-SA conjugate intravenously (IV)” NCT00988715 ↗ |